🇺🇸 Estradiol Tablets in United States

279 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Inappropriate Schedule Of Product Administration — 35 reports (12.54%)
  2. Metrorrhagia — 35 reports (12.54%)
  3. No Adverse Event — 30 reports (10.75%)
  4. Nausea — 29 reports (10.39%)
  5. Drug Ineffective — 27 reports (9.68%)
  6. Product Substitution Issue — 27 reports (9.68%)
  7. Product Use In Unapproved Indication — 27 reports (9.68%)
  8. Drug Dose Omission — 24 reports (8.6%)
  9. Product Dose Omission — 23 reports (8.24%)
  10. Vaginal Haemorrhage — 22 reports (7.89%)

Source database →

Estradiol Tablets in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Estradiol Tablets approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Estradiol Tablets in United States?

Copenhagen University Hospital at Herlev is the originator. The local marketing authorisation holder may differ — check the official source linked above.